I agree that this site is using cookies. You can find further informations here.
X
Poulouin, Yann
16  results:
Search for persons X
?
1

Safety of the PCSK9 inhibitor alirocumab: insights from 47 ..:

Goodman, Shaun G ; Steg, Philippe Gabriel ; Szarek, Michael...
European Heart Journal - Cardiovascular Pharmacotherapy.  , 2024
Link: https://doi.org/10.1093/..
 
?
2

Long‐Term Efficacy, Safety, and Tolerability of Alirocumab ..:

Goodman, Shaun G. ; Steg, Philippe Gabriel ; Poulouin, Yann...
Journal of the American Heart Association.  12 (2023)  18 - p. , 2023
Link: https://doi.org/10.1161/..
 
?
3

Effect of alirocumab on cataracts in patients with acute co..:

Suc, Gaspard ; Schwartz, Gregory G. ; Goodman, Shaun G....
BMC Ophthalmology.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
4

Correction: Effect of alirocumab on cataracts in patients w..:

Suc, Gaspard ; Schwartz, Gregory G. ; Goodman, Shaun G....
BMC Ophthalmology.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
5

Effect of Alirocumab on Incidence of Atrial Fibrillation Af..:

Lopes, Renato D. ; Guimarães, Patrícia O. ; Schwartz, Gregory G....
The American Journal of Medicine.  135 (2022)  7 - p. 915-918 , 2022
Link: https://doi.org/10.1016/..
 
?
6

LDL-C calculated by Friedewald, Martin-Hopkins, or NIH equa..:

Ginsberg, Henry N. ; Rosenson, Robert S. ; Hovingh, G. Kees...
Journal of Lipid Research.  63 (2022)  1 - p. 100148 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Effect of alirocumab on cataracts in patients with acute co..:

Suc, Gaspard ; Schwartz, Gregory G ; Goodman, Shaun G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276414/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
8

Long‐Term Efficacy, Safety, and Tolerability of Alirocumab ..:

Goodman, Shaun G ; Steg, Philippe Gabriel ; Poulouin, Yann...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547267/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

Correction: Effect of alirocumab on cataracts in patients w..:

Suc, Gaspard ; Schwartz, Gregory G ; Goodman, Shaun G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324219/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Treatment adherence and effect of concurrent statin intensi..:

Banach, Maciej ; López-Sendon, José Luis ; Averna, Maurizio...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924821/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

LDL-C calculated by Friedewald, Martin-Hopkins, or NIH equa..:

Ginsberg, Henry N ; Rosenson, Robert S ; Hovingh, G. Kees...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953656/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

Long‐Term Efficacy, Safety, and Tolerability of Alirocumab ..:

Shaun G. Goodman ; Philippe Gabriel Steg ; Yann Poulouin...
https://www.ahajournals.org/doi/10.1161/JAHA.122.029216.  , 2023
Link: https://doi.org/10.1161/..
 
?
13

Effect of alirocumab on cataracts in patients with acute co..:

Gaspard Suc ; Gregory G. Schwartz ; Shaun G. Goodman...
https://doi.org/10.1186/s12886-023-03012-1.  , 2023
Link: https://doi.org/10.1186/..
 
?
14

Correction: Effect of alirocumab on cataracts in patients w..:

Gaspard Suc ; Gregory G. Schwartz ; Shaun G. Goodman...
https://doi.org/10.1186/s12886-023-03065-2.  , 2023
Link: https://doi.org/10.1186/..
 
?
15

LDL-C calculated by Friedewald, Martin-Hopkins, or NIH equa..:

Henry N. Ginsberg ; Robert S. Rosenson ; G. Kees Hovingh...
http://www.sciencedirect.com/science/article/pii/S0022227521001310.  , 2022
Link: https://doi.org/10.1016/..
 
1-15